UK company offers portable diagnostics platform for rapid infectious disease testing and seeks commercial, licensing, investment, and R&D partners.
UK SME with a growing global presence has developed a low-cost, portable plasmonic PCR platform for rapid infectious disease detection. Direct sample input enables safe, on-site testing. With WHO procurement interest and active deployments, the company seeks commercial, licensing, and investment partners, and is open to research and regulatory collaboration in animal health and food diagnostics.